Company News: Merck (MRK) beats expectation

Market news

28 April 2015

Company News: Merck (MRK) beats expectation

Company reported Q1 earnings of $0.85 per share versus $0.75 consensus. Revenues fell 8.2% year/year to $9.43 bln versus $9.06 bln consensus.

Company issueed in-line guidance for FY15, sees EPS of $3.35-$3.48 versus $3.37 consensus and revenue of $38.3-$39.8 bln versus $39.23 consensus.

MRK rose to $59.66 (+4.48%) on the premarket.

U.S.: S&P/Case-Shiller Home Price Indices, y/y, February 5.0% (forecast 4.7%)

Company News: Pfizer (PFE) beats expectation

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.